Nintedanib Slows Decline in FVC in Autoimmune Disease-Linked ILD
Subgroup analysis performed for patients with autoimmune disease-related progressive fibrosing interstitial lung diseases
Respiratory Diseases/Disorders
Azithromycin and Recurrent Wheeze in Children After Severe RSV Bronchiolitis
Research presented at AAAAI assessed the effectiveness of oral azithromycin in reducing recurrent wheeze in young children.
Oral PDE4B Inhibitor Gets Breakthrough Tx Status for Idiopathic Pulmonary Fibrosis
BI 1015550 is an investigational oral phosphodiesterase 4B inhibitor with combined antifibrotic and anti-inflammatory effects.
FDA Grants Breakthrough Status to RSV Vaccine Candidate for Older Adults
MVA-BN RSV consists of 5 distinct RSV antigens to stimulate a broad immune response against both RSV subtypes A and B.
Dry Powder Inhalers Show Benefits for Asthma Control, Environment
Switching to dry powder inhaler more than halves carbon footprint of asthma treatment without asthma worsening
Group A Strep Infection Not Tied to Tics in Children With Family History
No association seen between GAS infections and tic onset among children with a first-degree relative with chronic tic disorder
FDA Fast Tracks Sabizabulin for COVID-19 Patients at High Risk for ARDS
Sabizabulin is a novel, oral cytoskeleton disruptor with both antiviral and anti-inflammatory properties.
Nucala 40mg Prefilled Syringe Approved for Children With Severe Eosinophilic Asthma
The FDA has approved a 40mg prefilled syringe for Nucala (mepolizumab) as add-on maintenance treatment for children with severe eosinophilic asthma.
FDA Rejects Gefapixant NDA for Chronic Cough
The application includes data from the two phase 3 studies, which evaluated the efficacy and safety of gefapixant in adults with refractory or unexplained chronic cough for at least 1 year.
Ryaltris Nasal Spray Approved for Seasonal Allergic Rhinitis
Ryaltris is a metered, fixed-dose nasal spray that delivers 665mcg of olopatadine hydrochloride and 25mcg of mometasone furoate in each spray.
